Concepedia

Ibrutinib promotes atrial fibrillation by inducing structural remodeling and calcium dysregulation in the atrium

Le Jiang, Linling Li, Yanfei Ruan, Xiaoyan Wu, Qianqian Zhao, Yanwei Xing, Xin Zhao, Shijun Xia, Rong Bai, Xin Du,

Heart Rhythm · 2019 · 106 citations · 15 references

DOI

Concepts

References

15

Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia

John C. Byrd, Jennifer R. Brown, Susan O’Brien et al. · New England Journal of Medicine · 2014 · 1.6K citations · Full text

, , +17

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia

Jan A. Burger, Alessandra Tedeschi, Paul M. Barr et al. · New England Journal of Medicine · 2015 · 1.6K citations · Full text

, , +11

Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia

John C. Byrd, Bonnie K. Harrington, Susan O’Brien et al. · New England Journal of Medicine · 2015 · 891 citations · Full text

, , +13

The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo

Sabine Ponader, Shih‐Shih Chen, Joseph J. Buggy et al. · Blood · 2011 · 635 citations · Full text

, , +15

Enhanced Sarcoplasmic Reticulum Ca <sup>2+</sup> Leak and Increased Na <sup>+</sup> -Ca <sup>2+</sup> Exchanger Function Underlie Delayed Afterdepolarizations in Patients With Chronic Atrial Fibrillation

Niels Voigt, Na Li, Qiongling Wang et al. · Circulation · 2012 · 622 citations · Full text

, , +17